ISAAC ROY: Open Payments
NPI 1033771860 · CLEVELAND, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,513 in 96 payments from 17 companies in 2025. Trend: 2023 $630 · 2024 $1,380 · 2025 $1,513
Food & beverage: $1,513
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $284 |
| ABBVIE INC. | 25 | $263 |
| Novartis Pharmaceuticals Corporation | 6 | $166 |
| GENZYME CORPORATION | 7 | $166 |
| PFIZER INC. | 6 | $111 |
| LEO Pharma Inc. | 4 | $100 |
| Lilly USA, LLC | 4 | $98 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 1 | $39 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, COSENTYX, CIBINQO, ADBRY, RINVOQ, EBGLYSS.
Industry payments across GA — which companies pay providers there.
